Skip to main content
Premium Trial:

Request an Annual Quote

CambridgeSoft to Develop, Market Molecular Connections' NetPro Database

NEW YORK (GenomeWeb News) — CambridgeSoft will develop, market, and sell Indian informatics company Molecular Connections’ NetPro database, the companies said today.
 
NetPro contains information on small-molecule interactions collected from literature that is relevant to drug interactions, metabolism, enzyme kinetics, and potential therapeutic agents.
 
Under the agreement, Cambridge, Mass.-based CambridgeSoft will use its ChemOffice technology to develop a version of NetPro that is searchable by chemical structure.
 
Bangalore, India-based Molecular Connections' NetPro includes small molecules in a number of categories, including metabolites, physiologically available bioactive molecules, ligands, enzyme activators and inhibitors, agonists and antagonists, and bio-hazardous molecules such as allergens, carcinogens, and toxicants.
 
The companies said the integrated product will allow chemists to find information on nearly 86,000 small-molecule interactions.
 
Financial terms of the agreement were not released.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more